Server was unable to process request. ---> The data types ntext and varchar are incompatible in the equal to operator. Incorrect syntax near ')'. Incorrect syntax near the keyword 'declare'. Khandwala Securities Limited.
NIFTY
-42.80  -0.48%
 8896.70
S&P BSE SENSEX
-80.09  -0.28%
 28812.88
Divis Laboratories Ltd.
NSE : DIVISLAB BSE : 532488 ISIN code : INE361B01024
on 27-Feb-2017
NSE
17.55    2.34%
Rs. 767.10
 
Days Low
Rs. 752.2
Days High
Rs. 779.05

Open Rs. 753.8
 
52 week Low
Rs. 672.2
52 week High
Rs.1380
 
 
Bid :                 0.00 (0)
Offer :        768.10 (1021)
BSE
Rs.768.10
18.8    2.51%
on 27-Feb-2017
BSE
18.8    2.51%
Rs. 768.10
 
Days Low
Rs. 751.95
Days High
Rs. 779

Open Rs. 754
 
52 week Low
Rs. 671.5
52 week High
Rs.1381.6
 
 
Bid :                 0.00 (0)
Offer :        768.10 (1021)
NSE
Rs.767.10
17.55    2.34%
 
 
Last Price (Rs.)  768.10 Value  194591762.00
Net Change (Rs.)  18.80 Best Buy  0.00
Volume  253593 Best Sell  768.10
Prev.Close (Rs.)  749.30 Best Quantity  0
Open (Rs.)  753.80 Sell Quantity  1021
High (Rs.)  779.05 52-Week High (Rs.)  1380.00
Low (Rs.)  752.20 52-Week Low (Rs.)  672.20
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  203906.42
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital530.94 265.47 265.47 
Share Capital530.94 265.47 265.47 
Share Capital530.94 265.47 265.47 
Share Capital530.94 265.47 265.47 
Share Capital530.94 265.47 265.47 
Currents Investments8025.25 7330.04 5018.76 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 674.85 1619162 89.42 0.00 0.15
Lupin 1463.80 660950 314.04 22.86 0.51
Dr. Reddys Lab 2857.90 473648 683.90 36.00 0.70
Cipla 585.45 470978 157.31 33.64 0.34
Cadila Healthcare 437.20 447580 64.69 22.64 0.73
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2016Sep 2016Jun 2016
Net Sales9630.509941.8010080.80
Operating Profit3992.703114.804200.60
PBDT3988.303110.904196.80
Net Profit2683.202238.503018.10
More> 
 
Company News
2/6/2017 12:00:00 AM
Divis Laboratories reports 9% growth in Q3FY17 net profit
1/23/2017 12:00:00 AM
Divis Laboratories informs about board meeting
1/9/2017 12:00:00 AM
Divis Laboratories informs about company updates
More>
 
Ratios
   Earnings Per Share (Rs)41.73 
   Book NAV/Share(Rs)163.87 
   PAT Margin (%)29.54 
   Asset Turnover(x)0.71 
   PER(x)23.61 
   Yield(%)1.02 
   EV/Core EBITDA(x)17.50 
   M Cap / Sales7.03 
   Net Sales Growth(%)20.67 
   PAT Growth(%)30.77 
   Total Debt/Equity(x)0.01 
   Current Ratio(x)4.27 
   Quick Ratio(x)2.81 
   Total Debt/Mcap(x)0.00 
More>